Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
Atlas Leans on Amgen, Novartis to Build New Startups 05/16/13 Boston
Radius Health CEO: Skin Patch Data is the Value Driver 05/13/13 Boston
NW Biotech Education Group Faces Loss of Federal Money, Deep Cuts 05/02/13 Seattle
Bind Therapeutics, AstraZeneca Collaborate on Cancer Drug 04/22/13 Boston
From Assets to Zen: Building Successful Drug Hunting Relationships 04/22/13 San Diego
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More 04/05/13 Boston
Bind Therapeutics Reels Pfizer into Nanomedicine Partnership 04/03/13 Boston
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
AstraZeneca Shells Out $240M Upfront For Moderna mRNA Drugs 03/21/13 Boston
Affymax Cuts 230 Jobs, Mulls Bankruptcy, After Drug Withdrawal 03/18/13 San Francisco
Has The Pendulum Swung Too Far in Favor of Rare Diseases? 03/14/13 Seattle
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
East Coast Life Sciences Roundup: Merck, Celgene, PTC, Cerulean 03/08/13 Boston
Roger Perlmutter Returns to Merck, Looks to Biotech Future (Again) 03/07/13 New York
Corporate Compliance Programs: The Importance of Being Effective 02/15/13 National
Ironwood Bucks the Trends, Makes Big Bet on Drug For Millions 02/06/13 Boston
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
Keryx Finally Succeeds With a Clinical Trial, for Kidney Disease Drug 01/28/13 New York
Alder Biopharma Looks to Take On Migraines, and the World 01/24/13 Seattle
VenBio’s Goodman Builds an Inside Periscope on Biotech Acquisitions 01/23/13 San Francisco
The Intersection of the Double Helix and Life Sciences in Seattle 01/22/13 Seattle
Boston’s Got Big Mo in Biotech, But SF is Pushing Back 01/21/13 National
East Coast Life Sciences Roundup: Bind, Boston Children’s, J&J, More 01/11/13 Boston
Mid-Priced Biotechnology Companies Bloom As M&A Targets in 2013 01/10/13 San Francisco
BIND CEO Says Amgen Deal Marks Nanomedicine Turning Point 01/09/13 Boston
Amgen in $180.5 Million Drug Development Deal with BIND Biosciences 01/08/13 Boston
My Report Card for JP Morgan Healthcare Conference Picks 01/07/13 National
Crescendo Bioscience Snags $28M For Arthritis Test 01/03/13 San Francisco
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
Page 1 of 11 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.